OpenAlex
PricingAboutJobs
Log inGet started
Work

Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist

HTML

Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Science Translational Medicine
DOI: 10.1126/scitranslmed.3009934
Authors: Yunzhao Tang, Annika S. Axelsson, Peter Spégel, Lotta E. Andersson, Hindrik Mulder, Leif C. Groop, Erik Renström, Anders H. Rosengren
Institutions: Lund University, Tianjin Medical University
Language: English

Topic: Pancreatic function and diabetes
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, ADRA2A, alpha2A-adrenergic receptor, yohimbine, personalized medicine, genetic risk variants, insulin secretion, disposition index, insulin sensitivity, polygenic disease
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk Fonden
Awards: G1524424421, G7713667241, G7868866864
OpenAlex ID: W2038460368
FWCI: 7.392
Cites: 30
Cited by: 84
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security